Cargando…

Use of Protamine in Nanopharmaceuticals—A Review

Macromolecular biomolecules are currently dethroning classical small molecule therapeutics because of their improved targeting and delivery properties. Protamine-a small polycationic peptide-represents a promising candidate. In nature, it binds and protects DNA against degradation during spermatogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruseska, Ivana, Fresacher, Katja, Petschacher, Christina, Zimmer, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230241/ https://www.ncbi.nlm.nih.gov/pubmed/34200384 http://dx.doi.org/10.3390/nano11061508

Ejemplares similares

Modified Stability of microRNA-Loaded Nanoparticles
por: Fresacher-Scheiber, Katja, et al.
Publicado: (2022)

Nanopharmaceutics
por: Ali, Javed
Publicado: (2011)

Internalization mechanisms of cell-penetrating peptides
por: Ruseska, Ivana, et al.
Publicado: (2020)

Trends in Nanopharmaceutical Patents
por: Antunes, Adelaide, et al.
Publicado: (2013)

Nanopharmaceuticals (part 1): products on the market
por: Weissig, Volkmar, et al.
Publicado: (2014)

Nanopharmaceuticals (part 2): products in the pipeline
por: Weissig, Volkmar, et al.
Publicado: (2015)

Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
por: Salama, Lavinia, et al.
Publicado: (2020)

Opportunities and obstacles to the development of nanopharmaceuticals for human use
por: Nassiri Koopaei, Nasser, et al.
Publicado: (2016)

Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications
por: Zielińska, Aleksandra, et al.
Publicado: (2021)

Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications
por: Zielińska, Aleksandra, et al.
Publicado: (2020)

Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use
por: Koopaei, Nasser Nassiri, et al.
Publicado: (2016)

Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
por: Souto, Eliana B., et al.
Publicado: (2020)

Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment
por: Lee, Hyeji, et al.
Publicado: (2022)

Assessment of multifunctional contrast agent probes in neuroimaging: Implications of nanopharmaceutical therapeutic interventions
por: Machtoub, Lina H.
Publicado: (2013)

Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
por: Souto, Eliana B., et al.
Publicado: (2020)

Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals
por: Thiyagarajan, Durairaj, et al.
Publicado: (2021)

Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
por: Ahmed, Osama A. A., et al.
Publicado: (2020)

Development and Characterization of Cationic Nanostructured Lipid Carriers as Drug Delivery Systems for miRNA-27a
por: Tucak-Smajić, Amina, et al.
Publicado: (2023)

The Use of Protamine Insulin
por: Nixon, J. A.
Publicado: (1938)

CRLX101 (formerly IT-101)–A Novel Nanopharmaceutical of Camptothecin in Clinical Development
por: Young, Cissy, et al.
Publicado: (2011)

Use of Insulin Lispro Protamine Suspension in Pregnancy
por: Lapolla, Annunziata, et al.
Publicado: (2015)

Protamine-Based Strategies for RNA Transfection
por: Jarzebska, Natalia Teresa, et al.
Publicado: (2021)

The expression, function, and utilization of Protamine1: a literature review
por: Ren, Shengnan, et al.
Publicado: (2021)

390 Protamine Allergy
por: Hafner, Christine, et al.
Publicado: (2012)

Protamine Zinc Insulin
Publicado: (1937)

Protamine Zinc Insulin
por: Bose, J. P.
Publicado: (1938)

Zinc Protamine Insulin
por: Dunlop, D. M.
Publicado: (1938)

The protamine family of sperm nuclear proteins
por: Balhorn, Rod
Publicado: (2007)

Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration
por: Scheicher, Bernhard, et al.
Publicado: (2016)

Polymorphisms in Protamine 1 and Protamine 2 predict the risk of male infertility: a meta-analysis
por: Jiang, Weijun, et al.
Publicado: (2015)

Recent Progress on Heparin–Protamine Particles for Biomedical Application
por: Hata, Yuuki, et al.
Publicado: (2022)

Drug Delivery From Polymer-Based Nanopharmaceuticals—An Experimental Study Complemented by Simulations of Selected Diffusion Processes
por: Macha, Innocent J., et al.
Publicado: (2019)

A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer
por: Liu, Fan, et al.
Publicado: (2023)

What is known so far about bull sperm protamination: a review
por: Nagaki, Carlos Alonso Paco, et al.
Publicado: (2022)

Studies on the Hemolytic Properties of Protamine
por: Becker, Frederick F.
Publicado: (1961)

Protamines and spermatogenesis in Drosophila and Homo sapiens: A comparative analysis
por: Kanippayoor, Rachelle L., et al.
Publicado: (2013)

Loss of the cleaved-protamine 2 domain leads to incomplete histone-to-protamine exchange and infertility in mice
por: Arévalo, Lena, et al.
Publicado: (2022)

Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles
por: Kishimoto, Satoko, et al.
Publicado: (2012)

Protamine loops DNA in multiple steps
por: Ukogu, Obinna A, et al.
Publicado: (2020)

Kounis Syndrome Induced by Protamine Sulfate
por: Amro, Mohammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6iokt2qjhu3t3g8h2b7a4gfc9l